Quantifying cardiovascular disease risk and heart age predictions for men in the prison environment.


Journal

Public health
ISSN: 1476-5616
Titre abrégé: Public Health
Pays: Netherlands
ID NLM: 0376507

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 07 06 2023
revised: 21 09 2023
accepted: 12 10 2023
medline: 5 12 2023
pubmed: 14 11 2023
entrez: 13 11 2023
Statut: ppublish

Résumé

Cardiovascular disease (CVD) and associated risk factors within the prison population often present at a younger age in this cohort. Given CVD is largely preventable, it warrants investigation to fully quantify this risk. This study explored the relative predicted 10-year CVD risk and examined the calculated heart age in a representative sample of male individuals aged 25-84 years within the prison environment. This was a cross-sectional study. Data were collected on 299 men who underwent a cardiometabolic risk assessment in HMP Parc, Bridgend. The QRISK2 algorithm was used to calculate 10-year CVD risk, relative risk (to general population) and the predicted heart age of an individual. Between-group differences (prison population vs general community) in cardiovascular risk predictions (10-year CVD risk and heart age) were assessed. We observed that at all age groups, the relative risk of predicted 10-year CVD scores in the prison population was double that of the community risk (2.1 ± 0.6), and this was most apparent in the oldest age group (≥50 years: 17.0% compared to 8.8%; P < 0.001). Overall, the heart age of the sample was 7.5 (6.7-8.2) years higher than their own chronological age, and this difference increased to above 9 years in those aged ≥40 years. This study provides quantifiable evidence to the elevated CVD risk in prison. Heart age predictions were almost a decade higher in those aged ≥40 years. Lowering the screening age for CVD by around 5 years in the prison population should be considered.

Identifiants

pubmed: 37956640
pii: S0033-3506(23)00394-3
doi: 10.1016/j.puhe.2023.10.026
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

285-290

Informations de copyright

Copyright © 2023 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Auteurs

B J Gray (BJ)

Health Protection, Public Health Wales, Cardiff, UK. Electronic address: Benjamin.Gray@wales.nhs.uk.

C Craddock (C)

Health Protection, Public Health Wales, Cardiff, UK.

Z Couzens (Z)

Health Protection, Public Health Wales, Cardiff, UK.

G J Dunseath (GJ)

Diabetes Research Group Swansea, Swansea University, UK.

A G Shankar (AG)

Health Protection, Public Health Wales, Cardiff, UK.

S D Luzio (SD)

Diabetes Research Group Swansea, Swansea University, UK.

S E Perrett (SE)

Health Protection, Public Health Wales, Cardiff, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH